{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:20:00Z","timestamp":1787671200071,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","jocn-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jocn.2018.09.019","type":"journal-article","created":{"date-parts":[[2018,10,28]],"date-time":"2018-10-28T22:17:31Z","timestamp":1540765051000},"page":"225-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Gabapentin or pregabalin induced myoclonus: A case series and literature review"],"prefix":"10.1016","volume":"61","author":[{"given":"Aaron","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazan","family":"Kherallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Marawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5\u20136","key":"10.1016\/j.jocn.2018.09.019_b0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neucli.2006.12.002","article-title":"Myoclonus and movement disorders","volume":"36","author":"Vercueil","year":"2006","journal-title":"Neurophysiol Clin"},{"key":"10.1016\/j.jocn.2018.09.019_b0010","first-page":"137","article-title":"Asterixis: one type of negative myoclonus","volume":"43","author":"Young","year":"1986","journal-title":"Adv Neurol"},{"issue":"8","key":"10.1016\/j.jocn.2018.09.019_b0015","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00415-016-8357-z","article-title":"The clinical heterogeneity of drug-induced myoclonus: an illustrated review","volume":"264","author":"Janssen","year":"2017","journal-title":"J Neurol"},{"issue":"10","key":"10.1016\/j.jocn.2018.09.019_b0020","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S1474-4422(04)00880-4","article-title":"Myoclonus: current concepts and recent advances","volume":"3","author":"Caviness","year":"2004","journal-title":"Lancet Neurol"},{"issue":"5\u20136","key":"10.1016\/j.jocn.2018.09.019_b0025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neucli.2006.12.003","article-title":"Drug-induced myoclonus: a French pharmacovigilance database study","volume":"36","author":"Brefel-Courbon","year":"2006","journal-title":"Neurophysiol Clin"},{"issue":"4","key":"10.1016\/j.jocn.2018.09.019_b0030","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1528-1157.2000.tb00192.x","article-title":"Myoclonus associated with the use of gabapentin","volume":"41","author":"Asconape","year":"2000","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.jocn.2018.09.019_b0035","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1046\/j.1528-1157.2001.44000.x","article-title":"Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin","volume":"42","author":"Huppertz","year":"2001","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.jocn.2018.09.019_b0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ncl.2009.09.003","article-title":"Neurologic presentations of renal diseases","volume":"28","author":"Lacerda","year":"2010","journal-title":"Neurol Clin"},{"issue":"9S","key":"10.1016\/j.jocn.2018.09.019_b0045","doi-asserted-by":"crossref","first-page":"S290","DOI":"10.1016\/j.pmrj.2016.07.323","article-title":"Poster 396 gabapentin-induced myoclonus in spinal cord injury","volume":"8","author":"Schnitzer","year":"2016","journal-title":"PM R"},{"issue":"7","key":"10.1016\/j.jocn.2018.09.019_b0050","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.parkreldis.2015.04.026","article-title":"Speech myoclonus due to probable pregabalin adverse drug-reaction","volume":"21","author":"Olszewska","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1016\/j.jocn.2018.09.019_b0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4103\/0971-4065.125102","article-title":"Pregabalin-associated myoclonic encephalopathy without evidence of drug accumulation in a patient with acute renal failure","volume":"24","author":"Courtois","year":"2014","journal-title":"Indian J Nephrol"},{"issue":"9","key":"10.1016\/j.jocn.2018.09.019_b0060","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jfma.2012.06.001","article-title":"Gabapentin-induced myoclonus in an elderly with end-stage renal failure","volume":"113","author":"Shea","year":"2014","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jocn.2018.09.019_b0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ebcr.2013.12.002","article-title":"Myoclonus in renal failure: two cases of gabapentin toxicity","volume":"2","author":"Kaufman","year":"2014","journal-title":"Epilepsy Behav Case Rep"},{"issue":"1","key":"10.1016\/j.jocn.2018.09.019_b0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/0971-4065.83744","article-title":"Treatment of gabapentin-induced myoclonus with continuous renal replacement therapy","volume":"22","author":"Guddati","year":"2012","journal-title":"Indian J Nephrol"},{"issue":"2","key":"10.1016\/j.jocn.2018.09.019_b0075","first-page":"138","article-title":"Two cases of pregabalin neurotoxicity in chronic kidney disease patients","volume":"4","author":"Lee","year":"2011","journal-title":"NDT Plus"},{"issue":"13","key":"10.1016\/j.jocn.2018.09.019_b0080","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/mds.22286","article-title":"Pregabalin- and gabapentin-associated myoclonus in a patient with chronic renal failure","volume":"24","author":"Healy","year":"2009","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.jocn.2018.09.019_b0085","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/j.ajkd.2009.04.014","article-title":"Treatment of pregabalin toxicity by hemodialysis in a patient with kidney failure","volume":"54","author":"Yoo","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.jocn.2018.09.019_b0090","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3340\/jkns.2008.43.5.237","article-title":"Myoclonus induced by the use of gabapentin","volume":"43","author":"Cho","year":"2008","journal-title":"J Korean Neurosurg Soc"},{"issue":"13","key":"10.1016\/j.jocn.2018.09.019_b0095","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/mds.21911","article-title":"Gabapentin-Induced myoclonus: case report","volume":"23","author":"Ege","year":"2008","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.jocn.2018.09.019_b0100","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.yebeh.2008.04.006","article-title":"Pregabalin-induced cortical negative myoclonus in a patient with neuropathic pain","volume":"13","author":"Hellwig","year":"2008","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.jocn.2018.09.019_b0105","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.0013-9580.2005.20804.x","article-title":"Gabapentin-induced myoclonus in end-stage renal disease","volume":"46","author":"Zhang","year":"2005","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.jocn.2018.09.019_b0110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00415-005-0970-1","article-title":"Gabapentin-induced severe myoclonus in a patient with impaired renal function","volume":"253","author":"Holtkamp","year":"2006","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.jocn.2018.09.019_b0115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/01.PHM.0000151943.06257.64","article-title":"Asterixis related to gabapentin as a cause of falls","volume":"84","author":"Babiy","year":"2005","journal-title":"Am J Phys Med Rehabil"},{"issue":"8","key":"10.1016\/j.jocn.2018.09.019_b0120","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1191\/0269216303Pm772cr","article-title":"Myoclonic jerks associated with gabapentin","volume":"17","author":"Scullin","year":"2003","journal-title":"Palliat Med"},{"key":"10.1016\/j.jocn.2018.09.019_b0125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ebcr.2012.10.003","article-title":"Myoclonic status epilepticus in six patients without epilepsy","volume":"1","author":"Baysal Kirac","year":"2013","journal-title":"Epilepsy Behav Case Rep"},{"issue":"4","key":"10.1016\/j.jocn.2018.09.019_b0130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/mds.25867","article-title":"The role of the cerebellum in the pathogenesis of cortical myoclonus","volume":"29","author":"Ganos","year":"2014","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.jocn.2018.09.019_b0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11940-016-0404-7","article-title":"Myoclonus: pathophysiology and treatment options","volume":"18","author":"Levy","year":"2016","journal-title":"Curr Treat Options Neurol"},{"issue":"3","key":"10.1016\/j.jocn.2018.09.019_b0140","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0091270003251119","article-title":"Pharmacokinetics of pregabalin in subjects with various degrees of renal function","volume":"43","author":"Randinitis","year":"2003","journal-title":"J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.jocn.2018.09.019_b0145","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","article-title":"A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin","volume":"49","author":"Bockbrader","year":"2010","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"10.1016\/j.jocn.2018.09.019_b0150","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.amjmed.2009.09.030","article-title":"Gabapentin toxicity in patients with chronic kidney disease: a preventable cause of morbidity","volume":"123","author":"Zand","year":"2010","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.jocn.2018.09.019_b0155","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/archneur.1994.00540180083018","article-title":"Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonists","volume":"51","author":"Pranzatelli","year":"1994","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.jocn.2018.09.019_b0160","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01243384","article-title":"Gabapentin augments whole blood serotonin in healthy young men","volume":"73","author":"Rao","year":"1988","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jocn.2018.09.019_b0165","first-page":"1011","article-title":"Mechanisms of new antiepileptic drugs","volume":"79","author":"Taylor","year":"1999","journal-title":"Adv Neurol"},{"issue":"2","key":"10.1016\/j.jocn.2018.09.019_b0170","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/clpt.1994.118","article-title":"Pharmacokinetics of gabapentin in subjects with various degrees of renal function","volume":"56","author":"Blum","year":"1994","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.jocn.2018.09.019_b0175","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMp1704633","article-title":"Gabapentin and pregabalin for pain \u2013 is increased prescribing a cause for concern?","volume":"377","author":"Goodman","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096758681830225X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096758681830225X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T20:23:08Z","timestamp":1662322988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096758681830225X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":35,"alternative-id":["S096758681830225X"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2018.09.019","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gabapentin or pregabalin induced myoclonus: A case series and literature review","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2018.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}